Anti-neprilysin drugs are mostly used for acute heart failure, cancer pain, hypertension, Alzheimer’s disease, and other diseases. The most commonly used anti-neprilysin is Sacubitril/valsartan thatis sold under the brand name Entrest. It consists of the neprilysin inhibitor sacubitril and the angiotensin receptor blocker valsartan. Entrest was first manufactured by Novartis International AG- a biopharmaceutical compay. This drug has reduced rate of cardiovascular deaths and hospitalizations related to heart failure. Due to increasing prevalence of heart failure, the U.S. Food And Drug Administration granted fast track designation to Entresto in 2015, which supports the FDA’s efforts to facilitate the development and expedite the review of drugs to treat serious or life-threatening conditions and meet the unmet medical needs of patients.
Market Dynamics
Increasing prevalence of acute heart failure is expected to drive the antineprilysin market growth over the forecast period. For instance, according to the data published in September 2020, by PubMed, a free search engine for biological databases and medical reports, Heart failure affects more than 64 million people every year worldwide. Attempts to decrease its social and economic burden have become a major global public health priority.
Key features of the study:
- This report provides an in-depth analysis of the global anti-neprilysin market and provides market size (US$ Mn) and compound annual growth rate (CAGR) for the forecast period 2025-2032, considering 2024 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global anti-neprilysin market based on the following parameters–Company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include BIOPROJET, Novartis AG, Pharmaleads SA, Theravance Biopharm, Cipla Inc, Oceanic Pharmachem Pvt. Ltd.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- Global anti-neprilysin market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global anti-neprilysin market
- Global Anti-Neprilysin Market, By Drug Type:
- Sacubitril
- TD-0714
- STR-324
- PL-265
- LHW-090
- Global Anti-Neprilysin Market, By Indication:
- Acute Heart Failure
- Cancer Pain
- Hypertension
- Alzheimer’s Disease
- Others
- Global Anti-Neprilysin Market, By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Global Anti-Neprilysin Market, By Region:
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC
- Israel
- Rest of Middle East
- Africa
- South Africa
- Central Africa
- North Africa
- Company Profiles
- BIOPROJET
- Novartis AG
- Pharmaleads SA
- Theravance Biopharm
- Cipla Inc
- Oceanic Pharmachem Pvt. Ltd.
- 1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- 2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Drug Type
- Market Snapshot, By Indication
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
- 3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Recent Product Launches
- Epidemiology
- Merger, Acquisition, and Collaborations
- Regulatory Scenario
- Key Developments
- PEST Analysis
- 4. Global Anti-Neprilysin Market– COVID-19 Impact Analysis
- Economic Impact
- COVID-19 Epidemiology
- Impact on Supply and Demand
- 5. Global Ant- Neprilysin Market, By Drug Type, 2020–2032, (US$ Mn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021–2032
- Segment Trends
- Sacubitril
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 – 2032, (US$ Mn)
- TD-0714
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 – 2032, (US$ Mn)
- STR-324
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 – 2032, (US$ Mn)
- PL-265
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 – 2032, (US$ Mn)
- LHW-090
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 – 2032, (US$ Mn)
- 6. Global Anti-Neprilysin Market, By Indication, 2020–2032, (US$ Mn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021–2032
- Segment Trends
- Acute Heart Failure
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 – 2032, (US$ Mn)
- Cancer Pain
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 – 2032, (US$ Mn)
- Hypertension
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 – 2032, (US$ Mn)
- Alzheimer’s Disease
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 – 2032, (US$ Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 – 2032, (US$ Mn)
- 7. Global Anti-Neprilysin Market, By Distribution Channel, 2020–2032, (US$ Mn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021–2032
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 – 2032, (US$ Mn)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 – 2032, (US$ Mn)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 – 2032, (US$ Mn)
- 8. Global Anti-Neprilysin Market, By Region, 2020–2032, (US$ Mn)
- Introduction
- Market Share Analysis, By Region, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Region, 2021–2032
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020 - 2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 – 2032, (US$ Mn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020 - 2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020– 2032, (US$ Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020 - 2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020– 2032, (US$ Mn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020 - 2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020– 2032, (US$ Mn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020 - 2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020– 2032, (US$ Mn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2020 - 2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Sub-region, 2020– 2032, (US$ Mn)
- North Africa
- Central Africa
- South Africa
- 9. Competitive Landscape
- BIOPROJET
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Novartis AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Pharmaleads SA
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Theravance Biopharm
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Cipla Inc
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Oceanic Pharmachem Pvt. Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- 10. Section
- Research Methodology
- About Us
- *Browse 34 market data tables and 36 figures on “Global Anti-Neprilysin Market” - Global forecast to 2032
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook